TESTESTETSTSETTSTTSTTSTSTS

Thumbnail image for Amanda Feilding’s speaks at Psychedelic Science 2013

Amanda Feilding’s speaks at Psychedelic Science 2013

May 1, 2013 Beckley in the Media

Read Amanda Feilding’s talk at the Psychedelic Science Conference 2013, held in Oakland California on 18-22 April. The conference was co-hosted by the Beckley Foundation, Multidisciplinary Association for Psychedelic Studies (MAPS), Heffter, and the Council for Spiritual Practices.

Continue Reading →
Thumbnail image for Psychedelic Science Conference 2013

Psychedelic Science Conference 2013

April 26, 2013 Beckley in the Media

The Psychedelic Science conference, co-hosted by the Beckley Foundation, brought together researchers from around the world to discuss research, clinical trials, and medical discoveries involving psychedelic substances. Amanda Feilding presented the results of the Beckley Foundation research programme, including our recent investigations into psilocybin and MDMA.

Continue Reading →
Thumbnail image for Amanda Feilding Interviewed in the Evening Standard

Amanda Feilding Interviewed in the Evening Standard

April 16, 2013 Beckley in the Media

Amanda talks about her life, psilocybin research and all Beckley Foundation projects in this interview with the Evening Standard.

Continue Reading →
Thumbnail image for Government Restrictions Obstruct Crucial Mental Health Research

Government Restrictions Obstruct Crucial Mental Health Research

April 15, 2013 Beckley in the Media

Current drug policies stifle important scientific and clinical research by placing an intolerable burden of regulation on scientists who wish to work with ‘controlled substances’, meaning that very few even try to do so.

Continue Reading →

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

October 15, 2012 BF Scientific Publications

A new analysis of the original psilocybin fMRI data has recently been published in a new paper in Schizophrenia Bulletin, in which the psychedelic state is analysed for similarity with early psychosis, as both share similar effects on how different areas of the brain communicate with eachother.

Continue Reading →

Are We Finally Reawakening to the Profound Healing Properties of Psychedelics?

June 18, 2012 MDMA

Legal research on a range of currently illegal drugs indicates they may help cure PTSD, alcoholism and even cluster headaches June 14, 2012  | Slowly but surely, we may be reaching success in a determined and long-time legal effort to unleash the curative powers of psychedelic drugs in America. There is a tremendous need for […]

Continue Reading →

Is the future of drugs safe and non-addictive?

June 11, 2012 Drug abuse

In years to come alcohol may be replaced with happier alternatives and we could all be immunised against developing harmful habits   The next 20 years hold great opportunities for drugs research. We could see the development of pharmacological substitutes, agents to block the effects of drugs and help people break addictions, and drug-based aids […]

Continue Reading →

Psilocybin’s effects on the brain and Aldous Huxley’s ‘reducing valve’ of consciousness: blog reaction to Beckley-Imperial Psilocybin research

January 27, 2012 LSD

In the popular science blog io9, Robert T. Gonzales ties up findings from this week’s Beckley Foundation-Imperial College Psilocybin paper in the PNAS with Aldous Huxley’s ‘reducing valve’ hypothesis, initially presented in his 1954 book The Doors of Perception (http://mescaline.com/huxley.htm); also, to more recent theorising by Karl Friston of University College London (http://www.fil.ion.ucl.ac.uk/~karl/), who postulates, in […]

Continue Reading →

Beckley Foundation-Imperial College collaboration publishes revolutionary research on effects of psilocybin on the brain

January 26, 2012 Press Releases

fMRI brain scans show that psilocybin, the active ingredient in magic mushrooms, lowers the activity of specific brain regions. The finding contradicts the popular belief that psychedelic drugs increase brain activity, and has far reaching implications for the therapeutic use of psilocybin in the treatment of depression and cluster headaches, as well as throwing light […]

Continue Reading →

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

January 3, 2012 BF Scientific Publications

The subjective effects of psychedelic drugs are caused by decreased activity and connectivity in the brain’s key connector hubs, enabling a state of unconstrained cognition.

Continue Reading →

Implications for psychedelic-assisted psychotherapy: a functional magnetic resonance imaging study with psilocybin

January 3, 2012 BF Scientific Publications

An observed switch in sensory function during recall from a pattern of deactivation under placebo to a pattern of activation under psilocybin may explain why memories can be felt as especially vivid or ‘real’ under psychedelics.

Continue Reading →

MDMA for treating post traumatic stress disorder: 80% success rate. Beckley Foundation’s work on psilocybin also praised

July 8, 2011 Beckley Science in the Media

An article posted by Craig K. Comstock on the Huffington Post talks of the huge success of Michael Mithoefer’s study into the medicinal purposes of MDMA, in particular reference to treating post traumatic stress disorder (PTSD). After MDMA-assisted psychotherapy, 80% no longer met the diagnostic criteria for PTSD, as compared to only 25% in the […]

Continue Reading →
Thumbnail image for Psilocybin Reduces Blood Flow to the Brain

Psilocybin Reduces Blood Flow to the Brain

May 16, 2011 Psilocybin

Psychedelic drug users throughout the ages have described their experiences as mind-expanding. They might be surprised, therefore, to hear that psilocybin – the active ingredient in magic mushrooms – actually decreases blood flow as well as connectivity between important areas of the brain that control perception and cognition. The same areas can be over-active in […]

Continue Reading →

The administration of psilocybin to healthy hallucinogen-experienced volunteers in a mock-fMRI environment: a preliminary investigation of tolerability

January 19, 2011 Beckley Science in the Media

Authors: Carhart-Harris RL¹², Williams TM², Sessa B², Tyacke RJ¹², Rich AS², Feilding A³, Nutt DJ¹² ¹ Imperial College London, Dept of Neuropsychopharmacology ² University of Bristol, Psychopharmacology Unit ³ The Beckley Foundation ²Corresponding author: r.carhart-harris@imperial.ac.uk Abstract: This study sought to assess the tolerability of intravenously administered psilocybin in healthy, hallucinogen-experienced volunteers in a mock-magnetic resonance […]

Continue Reading →

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

December 17, 2010 Psilocybin

Context: Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer. Objective: To explore the safety and efficacy of psilocybin […]

Continue Reading →

Effects of Psilocybin on Cerebral Blood Flow – Part of the Beckley/Imperial Psychedelic Research Programme

September 14, 2010 Psilocybin

Surprising findings of Research: Potential therapeutic applications of psychedelic drugs 25th January 2012 This work examines the effect of psilocybin on blood flow in the brain using fMRI. It is the first such study in the world and its results have been remarkable. It is a collaborative work between Professor David Nutt (Professor of Neuropsychopharmacology at […]

Continue Reading →

Psilocybin-Facilitated Treatment of Addiction – A Beckley Foundation/Johns Hopkins Collaboration

September 14, 2010 Psilocybin

The Beckley Foundation is proud to be collaborating with the distinguished team at Johns Hopkins University led by Professor Roland Griffiths and Assistant Professor Mathew Johnson, in the first study in modern times to harness the profound psychological effects of a psychedelic to aid the treatment one of the most difficult addictions to break: nicotine addiction […]

Continue Reading →

Psilocybin Introduction

September 14, 2010 Psilocybin

For many years the Beckley Foundation has been working at opening up psychedelic research in the UK. Finally we have been successful in initiating the first psychedelic imaging study using psilocybin and the latest brain imaging technology. The project is being run by Dr Robin Carhart-Harris and Professor David Nutt, Head of Neuropsychopharmacology at Imperial College London, […]

Continue Reading →
Thumbnail image for Psilocybin

Psilocybin

September 8, 2010 Psilocybin

This Program of research is part of a wider Beckley/Imperial Psychedelic Research Program which is investigating the neurophysiological effects of psychedelics. In the first study we measured effects of psilocybin on cerebral brain blood flow in 15 participants, using fMRI. Another study at Johns Hopkins University is investigating the use of Psilocybin in facilitating treatment […]

Continue Reading →
Thumbnail image for A Pilot Study of Psilocybin-Facilitated Addiction Treatment

A Pilot Study of Psilocybin-Facilitated Addiction Treatment

September 2, 2010 Psilocybin

The Beckley Foundation is proud to be collaborating with the distinguished team at Johns Hopkins University, led by Professor Roland Griffiths and Assistant Professor Matt Johnson, in the first study in modern times to harness the profound psychological effects of a psychedelic to aid the treatment of addiction.

Continue Reading →